Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li>On March 20, 2025, Abeona Therapeutics, Inc. (ABEO) announced financial results for the fourth quarter and full year of 2024 and provided a business update.</li><li>Preparations continue for the potential approval of prademagene zamikeracel (pz-cel), which has a PDUFA date of April 29, 2025.</li><li>Abeona disclosed that it received draft prescribing information on the label for pz-cel, which was in-line with company expectations.</li></ul>

On March 20, 2025, Abeona Therapeutics, Inc. (ABEO) announced financial results for the fourth quarter and full year of 2024 and provided a business update.Preparations continue for the potential approval of prademagene zamikeracel (pz-cel), which has a PDUFA date of April 29, 2025.Abeona disclosed that it received draft prescribing information on the label for pz-cel, which was in-line with company expectations.

ABEO: Countdown to PDUFA Date of April 29, 2025 